Molecular profiling and targeted inhibitor therapy in atypical chronic myeloid leukaemia in blast crisis

被引：5
|
作者：
Langabeer, Stephen E. [1 ]
Comerford, Claire M. [2 ]
Quinn, John [2 ]
Murphy, Philip T. [2 ]
机构：
[1] St James Hosp, Canc Mol Diagnost, Dublin, Ireland
[2] Beaumont Hosp, Dept Haematol, Dublin, Ireland
来源：
JOURNAL OF CLINICAL PATHOLOGY | 2017年 / 70卷 / 12期
关键词：
SORAFENIB;
D O I：
10.1136/jclinpath-2017-204621
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
[No abstract available]
引用
收藏
页码：1089 / 1089
页数：1
相关论文
共 50 条
  • [31] Lymphoid blast crisis during interferon-α therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis
    Goto, H
    Tsurumi, H
    Hara, T
    Moriwaki, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2000, 72 (04) : 474 - 476
  • [32] Imatinib mesylateFirst report of blast crisis in an elderly patient with chronic myeloid leukaemia: case report
    Reactions Weekly, 2003, 944 (1) : 9 - 9
  • [33] A case of chronic myeloid leukaemia presenting as megakaryocytic blast crisis (AML M7)
    Karkuzhali, Ponnuswamy
    Shanthi, Velusamy
    Usha, Thiruvengadam
    ECANCERMEDICALSCIENCE, 2013, 7
  • [34] Clinical efficacy of second generation tyrosine kinase inhibitor and 5-azacytidine combination in chronic myelogenous leukaemia in myeloid blast crisis
    Ghez, David
    Micol, Jean-Baptiste
    Pasquier, Florence
    Auger, Nathalie
    Saada, Veronique
    Spentchian, Marc
    Ianotto, Jean-Christophe
    Bourhis, Jean-Henri
    Bennaceur-Griscelli, Anelyse
    Terre, Christine
    Castaigne, Sylvie
    Rigaudeau, Sophie
    Rousselot, Philippe
    de Botton, Stephane
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (17) : 3666 - 3670
  • [35] The impact of gene profiling in chronic myeloid leukaemia
    Yong, Agnes S. M.
    Melo, Junia V.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (02) : 181 - 190
  • [36] Selective translational control by PABPC1 phase separation regulates blast crisis and therapy resistance in chronic myeloid leukaemia
    Chenguang Sun
    Xi Xu
    Zhongyang Chen
    Fanqi Zhou
    Wen Wang
    Junzhu Chen
    Mengyao Sun
    Fang Wang
    Linjia Jiang
    Ming Ji
    Siqi Liu
    Jiayue Xu
    Manman He
    Bowei Su
    Xiaoling Liu
    Yingdai Gao
    Hui Wei
    Jian Li
    Xiaoshuang Wang
    Meng Zhao
    Jia Yu
    Yanni Ma
    Nature Cell Biology, 2025, 27 (4) : 683 - 695
  • [37] Gene expression profiling of CD34+cells identifies a molecular signature of chronic myeloid leukemia blast crisis
    Zheng, C.
    Li, L.
    Haak, M.
    Brors, B.
    Frank, O.
    Giehl, M.
    Fabarius, A.
    Schatz, M.
    Weisser, A.
    Lorentz, C.
    Gretz, N.
    Hehlmann, R.
    Hochhaus, A.
    Seifarth, W.
    LEUKEMIA, 2006, 20 (06) : 1028 - 1034
  • [38] Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis
    C Zheng
    L Li
    M Haak
    B Brors
    O Frank
    M Giehl
    A Fabarius
    M Schatz
    A Weisser
    C Lorentz
    N Gretz
    R Hehlmann
    A Hochhaus
    W Seifarth
    Leukemia, 2006, 20 : 1028 - 1034
  • [39] The Depth Of 'Complete' Molecular Response Predicts Molecular Relapse In Chronic Myeloid Leukaemia Patients On Tyrosine Kinase Inhibitor Therapy
    Thomas, Heledd
    Apperley, Jane F.
    Szydlo, Richard M.
    Gerrard, Gareth
    Marin, David
    Milojkovic, Dragana
    Foroni, Letizia
    BLOOD, 2013, 122 (21)
  • [40] ATYPICAL BLAST CRISIS IN CHRONIC MYELOGENOUS LEUKEMIA
    KOROSTOFF, NR
    SUN, NCJ
    OKUN, DB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (12): : 1245 - 1246
12345